The prevalence, nature and impact of perioperative long COVID symptoms

  • Research type

    Research Study

  • Full title

    The prevalence, nature and impact of perioperative symptoms in patients undergoing elective surgery during the COVID pandemic.

  • IRAS ID

    291938

  • Contact name

    Caroline Thomas

  • Contact email

    caroline.thomas27@nhs.net

  • Sponsor organisation

    Leeds Teaching Hospitals NHS Trust

  • Duration of Study in the UK

    0 years, 5 months, days

  • Research summary

    1 in 200 people in the UK currently have coronavirus (COVID-19) with many more previously affected. 10% of those with COVID-19 subsequently develop symptoms such as shortness of breath and fatigue. The waiting list for planned surgery has increased throughout 2020 partly as a result of the pandemic. Testing is more widely available than earlier in 2020; people on the waiting list may have either had COVID-19 or have developed long tail COVID-19 symptoms without a positive test result. There is currently no accurate UK data on longer term COVID-19 symptoms in the perioperative population. We would like to find out more about the recovery from operations in people who have previously had COVID-19 or who have long tail COVID-19 symptoms. This is not to refuse operations for people with these symptoms or who have had COVID-19, but to better understand the needs and support the recovery of this patient group.
    We will contact people on our waiting list for planned surgery and ask about previous COVID-19 infection and any ongoing symptoms. We will ask questions lasting around 10 min over the telephone following verbal consent about whether people have had COVID-19 and whether they have any long tail symptoms. We will ask what these long tail symptoms are and how they affect the person’s daily life. We will ask a brief series of questions to everyone on the waiting list before and after their operation to find out about mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The last study contact will be 30 days after the operation. We will analyse the scores of two patient-reported outcome measure instruments (EQ5D and QoR15) to find out if there is difference between those who have had COVID-19 as well as to try to evaluate the impact of long tail COVID-19 symptoms.

  • REC name

    South Central - Berkshire B Research Ethics Committee

  • REC reference

    20/SC/0458

  • Date of REC Opinion

    5 Jan 2021

  • REC opinion

    Further Information Favourable Opinion